Eagle K A, Rihal C S, Mickel M C, Holmes D R, Foster E D, Gersh B J
University of Michigan Heart Care Program, Ann Arbor, Mich, USA.
Circulation. 1997 Sep 16;96(6):1882-7. doi: 10.1161/01.cir.96.6.1882.
The influence of prior coronary artery bypass surgery (CABG) versus medical therapy for reducing the risk of postoperative cardiac complications after noncardiac surgery continues to be debated. To further clarify this controversy we studied 24,959 participants in the Coronary Artery Surgery Study (CASS) database with suspected coronary disease by identifying those who required noncardiac surgery during more than 10 years of follow-up.
CASS registry enrollees were either treated with CABG or medical therapy after initial entry. During follow-up, patients who required noncardiac operations were evaluated for hospital death or out-of-hospital death within 30 days of noncardiac surgery and nonfatal postoperative myocardial infarction (MI). At a mean follow-up of 4.1 years, 3368 patients underwent noncardiac surgery, with abdominal (36%), urologic (21%), orthopedic (15%), and vascular being most common. Abdominal, vascular, thoracic, and head and neck surgery each had a combined MI/death rate among patients with nonrevascularized coronary disease >4%. Among 1961 patients undergoing higher-risk surgery, prior CABG was associated with fewer postoperative deaths (1.7% versus 3.3%, P=.03) and MIs (0.8% versus 2.7%, P=.002) compared with medically managed coronary disease. Contrariwise, 1297 patients undergoing urologic, orthopedic, breast, and skin operations had mortality of <1% regardless of prior coronary treatment. Prior CABG was most protective in patients with advanced angina and/or multivessel coronary artery disease.
In patients with known coronary artery disease, noncardiac surgeries involving the thorax, abdomen, vasculature, and head and neck are associated with the highest cardiac risk, which is reduced among patients with prior CABG.
冠状动脉搭桥术(CABG)与药物治疗相比,在降低非心脏手术后心脏并发症风险方面的影响仍存在争议。为进一步阐明这一争议,我们通过识别在超过10年随访期间需要进行非心脏手术的患者,对冠状动脉手术研究(CASS)数据库中的24959名疑似冠心病参与者进行了研究。
CASS登记参与者在初次入选后接受CABG或药物治疗。在随访期间,对需要进行非心脏手术的患者在非心脏手术后30天内的院内死亡或院外死亡以及非致命性术后心肌梗死(MI)进行评估。平均随访4.1年时,3368例患者接受了非心脏手术,其中腹部手术(36%)、泌尿外科手术(21%)、骨科手术(15%)和血管手术最为常见。腹部、血管、胸部以及头颈外科手术在未进行血运重建的冠心病患者中,MI/死亡率均超过4%。在1961例接受高风险手术的患者中,与药物治疗的冠心病患者相比,既往CABG与较少的术后死亡(1.7%对3.3%,P=0.03)和MI(0.8%对2.7%,P=0.002)相关。相反,1297例接受泌尿外科、骨科、乳腺和皮肤手术的患者,无论既往冠状动脉治疗情况如何,死亡率均<1%。既往CABG对晚期心绞痛和/或多支冠状动脉疾病患者的保护作用最为明显。
在已知冠心病患者中,涉及胸部、腹部、血管系统和头颈的非心脏手术心脏风险最高,而既往接受CABG的患者风险降低。